Page Title
Drug Development Pipeline
Back to the Drug Development Pipeline
Denufosol
Status
DiscontinuedTherapeutic Approach
Mucociliary Clearance
This alternative chloride channel activator has been removed from the pipeline due to lack of efficacy.
Status
No further clinical development is planned at this time.
Sponsor
This program was sponsored by Inspire Pharmaceuticals.
Recent Denufosol Studies
-
Completed with Results
Denufosol Inhalation Solution in People With Mild CF Lung Disease (TIGER 2) (Inspire 08-110)

CONTACT THE CLINICAL TRIAL NAVIGATOR
Get personalized assistance and answers to your clinical trial questions.
Learn MoreSign up for clinical trial alerts
Get email updates about clinical trials that matter to you.
Explore clinical trials
Be a part of the movement transforming the future of cystic fibrosis treatment.
Learn More